Table 1.

Inputs and risks for modelling the comparative risk of KMC versus COVID-19 for two scenarios.

	Baseline coverageˆ	Coverage reduction	SARS-CoV-2 positive mothers	Transmission rate*	Mortality risk†
1. Maximum benefit vs maximum harm	99	0	15	100/30/20/10	0•5
2. Additional deaths due to coverage reduction	20	50/100	NA‡	NA‡	NA‡

All figures are expressed as percentages.

^ˆBaseline coverage of KMC among neonates weighing ≤2000 g who are born in a facility.

^⁎Rate of SARS-CoV-2 transmission from mother or surrogate to neonate.

^†Estimated mortality risk due to COVID-19 among neonates weighing ≤2000 g, based on the following assumptions: case fatality rate 0•5% [19]; KMC reduces mortality by 40% [8].

^‡NA, not applicable.